COVID-19 and chronic kidney disease: a bibliometric analysis
Wenze Jiang, Yuting Chen, Yuxin Zhao, Yang Gao, Tianyang Cheng, Enhui Qian, Yating Hou, Keda Lu- General Medicine
- Surgery
Background:
The coronavirus disease 2019(COVID-19) pandemic has caused over 656 million confirmed cases and over 6.6 million deaths worldwide. Chronic kidney disease (CKD) is considered a high-risk factor for COVID-19; therefore, considerable research has been conducted in this field. Therefore, this study aims to conduct a bibliometric analysis of publications related to COVID-19 and CKD.
Methods:
Publications were retrieved from the Web of Science Core Collection database on January 16, 2023 and screened based on inclusion criteria. Then we used Microsoft Excel and CiteSpace to analyze the included publications from the following seven aspects: countries/regions, institutions, journals, authors, cited references, and keywords.
Results:
In total, 622 publications were included in the study. The USA has the most publications in this field, followed by China. The Icahn School of Medicine at Mount Sinai and Harvard Medical School had the highest number of publications in the field.
Conclusions:
The USA, China, and some European countries and their institutions are major contributors to these publications. End-stage renal disease, acute kidney injury, kidney transplantation and convalescent plasma are current hot topics in the field.